Form 4: ATI Physical Therapy Director John L. Larsen Reports Stock Option Grants

Sentiment:

SEC Form 4 Filing


Director John L. Larsen reports the acquisition of multiple stock option grants in ATI Physical Therapy, Inc.

Summary

  • John L. Larsen, a director of ATI Physical Therapy, Inc., filed a Form 4 disclosing changes in his beneficial ownership.
  • The report details the acquisition of several stock option grants on August 20, 2024, with varying exercise prices and vesting schedules.
  • These options give Larsen the right to buy Class A Common Stock at prices ranging from $10 to $50, with expiration dates in 2034.
  • Larsen also holds stock options granted on November 23, 2021, and March 7, 2022, which have been adjusted to reflect a reverse stock split on June 14, 2023.
  • The vesting schedules for these options are generally one-third vesting annually, contingent on continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants, which is neither overtly positive nor negative.

Positives

  • The acquisition of stock options by a director can be seen as a positive sign, aligning the director's interests with those of the shareholders.
  • The vesting schedules provide an incentive for the director to remain with the company and contribute to its long-term success.

Risks

  • The value of the stock options is dependent on the future performance of ATI Physical Therapy's stock price.
  • If the stock price does not increase above the exercise prices, the options may not be valuable to the director.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the vesting schedules of the stock options suggest a multi-year commitment from the director.

Industry Context

Stock option grants are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

  • Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in growth-oriented sectors like healthcare.
  • Companies like UnitedHealth Group (UNH) and HCA Healthcare (HCA) also utilize stock options as part of their executive compensation plans.
  • The vesting schedules and exercise prices are generally aligned with industry norms to incentivize long-term performance and retention.

Stakeholder Impact

  • The stock option grants could potentially incentivize the director to make decisions that increase shareholder value.
  • Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
11/23/2021Date of original stock option grant with an exercise price of $171.
03/07/2022Date of original stock option grant with an exercise price of $87.
06/14/2023Date of reverse stock split that adjusted previous stock option grants.
08/09/2024One-third of the Stock Options vested on this date.
08/20/2024Date of new stock option grants with exercise prices of $10, $12.50, $25, and $50.
08/22/2024Date of the Form 4 filing.
04/01/2025First vesting date for one-third of the stock options granted on August 20, 2024.
04/01/2026Second vesting date for one-third of the stock options granted on August 20, 2024.
04/01/2027Final vesting date for one-third of the stock options granted on August 20, 2024.
11/23/2031Expiration date for stock options granted on November 23, 2021.
03/07/2032Expiration date for stock options granted on March 7, 2022.
08/20/2034Expiration date for stock options granted on August 20, 2024.

Keywords

stock options, Form 4, beneficial ownership, ATI Physical Therapy, director, Larsen, ATIP, vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.